Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Identification of Recurrent Alternative RNA Splicing in Adverse-Risk Acute Myeloid Leukemia

Govardhan Anande, Ashwin Unnikrishnan, PhD, Nandan Deshpande, PhD, Sylvain Mareschal, Aarif M. N. Batcha, Tobias Herold, MD, Sören Lehmann, MD PhD, Marc Wilkins, PhD, Jason Wong, PhD, John Pimanda, MBBS, PhD

Blood (2019) 134 (Supplement_1): 457.

https://doi.org/10.1182/blood-2019-129537

Published: 2019

Journal Articles

High-Throughput Functional Ex-Vivo Drug Testing and Multi-Omics Profiling in Patients with Acute Myeloid Leukemia

Tom Erkers, PhD, Brinton Seashore-Ludlow, Nona Struyf, Francesco Marabita, Tojo James, Disha Malani, Mattias Vesterlund, Matthias Stalhl, Yudi Pawitan, Sören Lehmann, MD PhD, Päivi Östling, Janne Lehtiö, Olli Kallioniemi

Blood (2019) 134 (Supplement_1): 4641.

https://doi.org/10.1182/blood-2019-124332

Published: 2019

Journal Articles

Single-Cell Analysis of the Transcriptional Response in AML Patients Treated with BET-Inhibitors

Sophia Miliara, BSc, MSc, PhD, Bogumil Kaczkowski, PhD, Takahiro Suzuki, PhD, Huthayfa Mujahed, MSc, Maasaki Furuno, PhD, Satoshi Takizawa, Harukazu Suzuki, PhD, Takahiro Arakawa, Soren Lehmann, MD PhD, Andreas Lennartsson, PhD, Erik Arner, PhD

Blood (2018) 132 (Supplement 1): 5120.

https://doi.org/10.1182/blood-2018-99-117849

Published: 2018

Journal Articles

Phenotypic and Functional Alterations of Bone Marrow Mesenchymal Stem and Progenitor Cells in Chronic Myeloid Leukemia

Monika Dolinska, Johannis Klang, Pingnan Xiao, MD, Andranik Durgaryan, Lakshmi Sandhow, Anne-Sofie Johansson, Makoto Kondo, Stefan Deneberg, MD, PhD, Johanna Ungerstedt, Associate Professor, Katarina Le Blanc, MD, PhD, Leif Stenke, MD PhD, Marja Ekblom, Ulla Stromberg, MDPhD, Satu Mustjoki, MD PhD, Soren Lehmann, MD PhD, Hong Qian, PhD

Blood (2015) 126 (23): 2398.

https://doi.org/10.1182/blood.V126.23.2398.2398

Published: 2015

Journal Articles

Bone Marrow Fibroblasts Derived from Vitally Frozen Mononuclear Cells As a Source for Germ Line DNA in Acute Myeloid Leukemia (AML)

Huthayfa Mujahed, MSc, Deneberg Stefan, Soren Lehmann, MD PhD

Blood (2015) 126 (23): 2606.

https://doi.org/10.1182/blood.V126.23.2606.2606

Published: 2015

Journal Articles

Early Disease Relapse after Tyrosine Kinase Inhibitor Treatment Discontinuation in CML Is Related Both to Low Number and Impaired Function of NK-Cells

Blood (2014) 124 (21): 812.

https://doi.org/10.1182/blood.V124.21.812.812

Published: 2014

Journal Articles

Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013

Gunnar Juliusson, MD PhD, Vladimir Lazarevic, MD, Sören Lehmann, MD PhD, Åsa Rangert Derolf, MD PhD, Lars Möllgård, MDPhD, Hege Garelius, MD, Lovisa Wennström, MD PhD, Bertil Uggla, MD PhD, Petar Antunovic, MD, Kristina Myhr-Eriksson, MD, Anders Wahlin, MD PhD, Martin Höglund, MDPhD

Blood (2014) 124 (21): 2269.

https://doi.org/10.1182/blood.V124.21.2269.2269

Published: 2014

Journal Articles

Mutations in Histone Modulators and HOXA5 Methylation Levels Affects Survival in Azacitidine Treated MDS Patients

Magnus Tobiasson, MD, Mohsen Karimi, Marios Dimitriou, Ying Qu, MDM.Sc, Andreas Lennartsson, PhD, Hani Abdulkadir Ali, Ashwin Unnikrishnan, PhD, Martin Jadersten, MDPhD, Monika Jansson, Asmaa Ben Azenkoud, John E Pimanda, MD PhD, Karl Ekwall, Prof, Johanna Ungerstedt, MD PhD, Soren Lehmann, MD PhD, Eva Hellstrom-Lindberg, MD PhD

Blood (2014) 124 (21): 4613.

https://doi.org/10.1182/blood.V124.21.4613.4613

Published: 2014

Journal Articles

Disease Relapse After TKI Discontinuation In CML Is Related Both To Low Number and Impaired Function Of NK-Cells:Data From Euro-SKI

Blood (2013) 122 (21): 379.

https://doi.org/10.1182/blood.V122.21.379.379

Published: 2013

Journal Articles

The Interlaboratory Robustness of Next-Generation Sequencing (IRON) Study Phase II: Deep-Sequencing Analyses of Hematological Malignancies Performed by an International Network Involving 26 Laboratories

Blood (2012) 120 (21): 1399.

https://doi.org/10.1182/blood.V120.21.1399.1399

Published: 2012

Journal Articles

Poor Outcome in Secondary Acute Myeloid Leukemia (AML): A First Report From the Population-Based Swedish Acute Leukemia Registry

Soren Lehmann, MD, PhD, Vladimir Lazarevic, MD, Ann-Sofi Hörstedt, Erik Hulegårdh, MD, Christer Nilsson, MD, Petar Antunovic, MD, Åsa Rangert Derolf, MD, PhD, Lars Möllgård, MD, PhD, Bertil Uggla, MD, PhD, Lovisa Vennström, MD, Anders Wahlin, MD, PhD, Martin Hoglund, MD, PhD, Dick Stockelberg, MD, PhD, Gunnar Juliusson, MD, PhD

Blood (2012) 120 (21): 130.

https://doi.org/10.1182/blood.V120.21.130.130

Published: 2012

Journal Articles

In Vitro and Ex Vivo Studies On Cell Lines and Primary Human Leukemia Cells of the Effects of APR-246 Alone and in Combination with Conventional Chemotherapeutic Drugs.

Kerstin Jonsson-Videsater, Dina Ali, MD, Hareth Nahi, Sofia Bengtzen, Stefan Deneberg, Christer Paul, Professor, Soren Lehmann, MD, PhD

Blood (2009) 114 (22): 2751.

https://doi.org/10.1182/blood.V114.22.2751.2751

Published: 2009

Journal Articles

Low Expression of p14 ARF in De Novo AML with Normal Karyotype Is Associated with Short Survival but Increased in Vitro Sensitivity to p53 Modulating Drugs

Esbjörn Paul, Bertil Uggla, Kals G Wiman, Christer Paul, Soren Lehmann, MD, PhD, Hareth Nahi

Blood (2008) 112 (11): 2937.

https://doi.org/10.1182/blood.V112.11.2937.2937

Published: 2008

Journal Articles

Expression of p14ARF in De Novo AML with Normal Karyotype. Implication on Drug Resistance and Survival.

Esbjorn O. Paul, MD, Stefan Deneberg, MD, Soren Lehmann, MD, PhD, Sofia Bengtzén, Ms., Hareth Nahi, MD, PhD.

Blood (2007) 110 (11): 4261.

https://doi.org/10.1182/blood.V110.11.4261.4261

Published: 2007

Journal Articles

Factors Affecting Long-Term Survival in Non-Transplanted Acute Myeloid Leukemia Patients.

Anna H. Lof, Soren Lehmann, MD, PhD

Blood (2007) 110 (11): 4371.

https://doi.org/10.1182/blood.V110.11.4371.4371

Published: 2007

Journal Articles

Identification of Pathogenetically Important Genes within the Common Deleted Region (CDR) of the 5q- Syndrome.

Soren Lehmann, MD, PhD, Sophie Raynaud, MD, Julian C. Desmond, PhD, Phillip H. Koeffler, MD

Blood (2005) 106 (11): 3439.

https://doi.org/10.1182/blood.V106.11.3439.3439

Published: 2005

NARROW

Identification of Recurrent Alternative RNA Splicing in Adverse-Risk Acute Myeloid Leukemia

High-Throughput Functional Ex-Vivo Drug Testing and Multi-Omics Profiling in Patients with Acute Myeloid Leukemia

Single-Cell Analysis of the Transcriptional Response in AML Patients Treated with BET-Inhibitors

Phenotypic and Functional Alterations of Bone Marrow Mesenchymal Stem and Progenitor Cells in Chronic Myeloid Leukemia

Bone Marrow Fibroblasts Derived from Vitally Frozen Mononuclear Cells As a Source for Germ Line DNA in Acute Myeloid Leukemia (AML)

Early Disease Relapse after Tyrosine Kinase Inhibitor Treatment Discontinuation in CML Is Related Both to Low Number and Impaired Function of NK-Cells

Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013

Mutations in Histone Modulators and HOXA5 Methylation Levels Affects Survival in Azacitidine Treated MDS Patients

Disease Relapse After TKI Discontinuation In CML Is Related Both To Low Number and Impaired Function Of NK-Cells:Data From Euro-SKI

The Interlaboratory Robustness of Next-Generation Sequencing (IRON) Study Phase II: Deep-Sequencing Analyses of Hematological Malignancies Performed by an International Network Involving 26 Laboratories

Poor Outcome in Secondary Acute Myeloid Leukemia (AML): A First Report From the Population-Based Swedish Acute Leukemia Registry

In Vitro and Ex Vivo Studies On Cell Lines and Primary Human Leukemia Cells of the Effects of APR-246 Alone and in Combination with Conventional Chemotherapeutic Drugs.

Low Expression of p14 ARF in De Novo AML with Normal Karyotype Is Associated with Short Survival but Increased in Vitro Sensitivity to p53 Modulating Drugs

Expression of p14ARF in De Novo AML with Normal Karyotype. Implication on Drug Resistance and Survival.

Factors Affecting Long-Term Survival in Non-Transplanted Acute Myeloid Leukemia Patients.

Identification of Pathogenetically Important Genes within the Common Deleted Region (CDR) of the 5q- Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only